Quoin Pharmaceuticals, Ltd. (QNRX) Tops Q4 EPS by 10c

Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q4 EPS of ($0.41), $0.10 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.

You May Also Be Interested In

• Ciena beats estimates on strong AI-driven demand, shares rise
• MediaAlpha names new CFO and raises Q3 2026 guidance
• Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance